Prescription drugs obscure microbiome analyses

Science

Volumn 351, Issue 6272, 2016, Pages 452-453

  Devkota, Suzanne ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN; PRESCRIPTION DRUG;

ANTIBIOTICS; CONCENTRATION (COMPOSITION); DISEASE TREATMENT; DRUG; GENE EXPRESSION; GLUCOSE; MICROBIAL COMMUNITY; NANOPARTICLE;

GENE EXPRESSION; GLUCONEOGENESIS; HUMAN; INTESTINE FLORA; MICROBIAL GENE; MICROBIOME; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; REVIEW; DRUG EFFECTS; FEMALE; MALE; MICROBIOLOGY; PHYSIOLOGY;

DIABETES MELLITUS, TYPE 2; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; MALE; METFORMIN;

EID: 84956742837     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.aaf1353     Document Type: Review

References (9)

1. K. Forslund et al., Nature 528, 262 (2015).
2. E. Le Chatlier et al., Nature 500, 541 (2013).
3. F.H. Karlsson et al., Nature 498, 99 (2013).
4. J. Qin et al., Nature 490, 55 (2013).
5. C.F. Maurice et al., Cell 152, 39 (2013).
6. H.J. Haiser et al., Science 341, 295 (2013).
7. N. Shin et al., Gut 63, 727 (2014).
8. M. Croset et al., Diabetes 50, 740 (2001).
9. Y. Zhao et al., J. Am. Chem. Soc. 135, 12940 (2013).